miR‑543 Acts as a Novel Oncogene in Oral Squamous Cell Carcinoma by Targeting CYP3A5

Oncology Reports - Greece
doi 10.3892/or.2019.7230
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

MiR-1254 Functions as a Tumor Suppressor in Oral Squamous Cell Carcinoma by Targeting CD36

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2019English

miR-216a-5p Acts as an Oncogene in Renal Cell Carcinoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

miR-181a Decelerates Proliferation in Cutaneous Squamous Cell Carcinoma by Targeting the Proto-Oncogene KRAS

PLoS ONE
Multidisciplinary
2017English

Tropomyosin-1 Acts as a Potential Tumor Suppressor in Human Oral Squamous Cell Carcinoma

PLoS ONE
Multidisciplinary
2017English

Membrane Connexin 43 Acts as an Independent Prognostic Marker in Oral Squamous Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2014English

Long Noncoding RNA GAS5 Acts as a Tumor Suppressor in Laryngeal Squamous Cell Carcinoma via miR-21

Cancer Management and Research
Oncology
2019English

miR-630 Functions as a Tumor Oncogene in Renal Cell Carcinoma

Archives of Medical Science
Medicine
2016English

Histone Deacetylase 8 as a Novel Therapeutic Target in Oral Squamous Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

circRNA_0000140 Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting miR-31 to Inhibit Hippo Signaling Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy